Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1995-10-18
|
pubmed:abstractText |
In this study, it is examined whether the organotin compound di-n-butyltindichloride (DBTC), which has been shown to inhibit immature thymocyte proliferation, is able to disturb the binding between thymocytes and thymic epithelial cells (TEC). To that end, an enzyme-linked binding assay was developed in which the amount of binding of Thy-1+ (mAb ER4)-thymocytes to the rat-derived TEC-line IT45R1 (IT45R1-TEC) could be detected. It was found that preincubation of thymocytes with 3-5 microM DBTC for 30 min inhibited the binding by 50-60% during a 1 h adhesion period. By extending the preincubation period to 1 h and the adhesion period to 22 h, 0.1 microM DBTC was already sufficient to reduce the binding with 60-80%. Further characterization of the binding revealed that splenic lymphocytes were unable to bind to the MHC class II-negative IT45R1-TEC. Since dextran sulfate inhibited the binding as well, sulfated polysaccharide-binding molecules such as Thy-1 and CD2 are likely to be involved in the binding. Electron microscopy showed filament-containing microvilli at the site of interaction. The results are discussed in relation to the mechanism of DBTC-induced thymus atrophy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD2,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Thy-1,
http://linkedlifedata.com/resource/pubmed/chemical/Dextran Sulfate,
http://linkedlifedata.com/resource/pubmed/chemical/Histocompatibility Antigens Class II,
http://linkedlifedata.com/resource/pubmed/chemical/Organotin Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/dibutyldichlorotin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0192-0561
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
329-37
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7672883-Animals,
pubmed-meshheading:7672883-Antigens, CD2,
pubmed-meshheading:7672883-Antigens, Thy-1,
pubmed-meshheading:7672883-Atrophy,
pubmed-meshheading:7672883-Cell Adhesion,
pubmed-meshheading:7672883-Cell Line,
pubmed-meshheading:7672883-Depression, Chemical,
pubmed-meshheading:7672883-Dextran Sulfate,
pubmed-meshheading:7672883-Epithelium,
pubmed-meshheading:7672883-Histocompatibility Antigens Class II,
pubmed-meshheading:7672883-Microscopy, Electron,
pubmed-meshheading:7672883-Organotin Compounds,
pubmed-meshheading:7672883-Rats,
pubmed-meshheading:7672883-T-Lymphocyte Subsets,
pubmed-meshheading:7672883-Thymus Gland
|
pubmed:year |
1995
|
pubmed:articleTitle |
The thymus atrophy-inducing organotin compound DBTC inhibits the binding of thymocytes to thymic epithelial cells.
|
pubmed:affiliation |
Research Institute of Toxicology, University of Utrecht, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|